CA
NZ
UK
AU
IND
US
Talks at the Bürgenstock resort extended into the early hours of Monday morning, with senior officials from both the Pakistani and Iranian delegations describing the atmosphere as constructive but tense. The joint statement from Qatar and Pakistan confirmed encouraging progress while carefully avoiding the …
Starmer said he would resign as leader of the Labour Party after speaking to King Charles, adding that he had asked the National Executive Committee to set out a timetable with nominations opening July 9 and completed by the summer recess.
The US 10-year Treasury yield's drift higher on Monday reflected a tug of war between two competing forces. Iran deal progress from the Lake Lucerne Summit, where the US and Iran agreed on a roadmap toward a final agreement within 60 days and established …
SK Hynix closed up 5.6% on Monday, lifting its market capitalisation to 2,080.4 trillion won ($1.35 trillion) and overtaking Samsung Electronics at 2,066.7 trillion won excluding preferred shares. Samsung said any calculation of its market capitalisation should include preferred shares, which would bring the …
China's Commerce Ministry added MP Materials (NYSE: MP) and USA Rare Earth (NASDAQ: USAR), along with eight other US entities it linked to the US military, to its export control list on Monday. The measures are a response to what Beijing described as the …
China's Commerce Ministry added MP Materials (NYSE: MP) and USA Rare Earth (NASDAQ: USAR) to its export control list on Monday in a move that represents the most direct targeting of US domestic rare earth infrastructure since the critical minerals trade conflict began in …
Jet fuel prices nearly doubled after the Iran war began, forcing airlines to cut routes and absorb costs before passing them through to passengers across seven successive fare increases. The ceasefire and Hormuz reopening now reverse the fuel cost direction, but the revenue management …
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) is trading at $8.32 pre-market June 22, up 3.35% from the June 18 close of $8.05. SELLAS is a late-stage clinical biopharmaceutical company developing novel cancer immunotherapies, with lead candidate galinpepimut-S (GPS), a peptide immunotherapy targeting the …
Definium Therapeutics, Inc. (NASDAQ: DFTX), formerly known as Mind Medicine (MindMed) Inc., is trading at $27.38 pre-market June 22, up 11.85% from the June 18 close of $24.48. Definium is a New York-based late-stage clinical biopharmaceutical company developing next-generation psychedelic-based therapeutics targeting underlying causes …
Nektar Therapeutics (NASDAQ: NKTR) is trading at $63.89 pre-market June 22, up 4.77% from the June 18 close of $60.98. Nektar is a clinical-stage biopharmaceutical company focused on immunological dysfunction in autoimmune, chronic inflammatory diseases, and oncology, with lead asset rezpegaldesleukin (REZPEG/NKTR-358), a first-in-class …
Please wait processing your request...